Clinical Trials Market Analysis, Size, Share, Growth, Trends, and Forecasts 2030

Share This Article

According to recent market study published by Precedence Research Market reports titled, “Global Clinical Trials Market Size, Share, Trends Analysis , Opportunity and Forecast, 2021-2030”, The global clinical trials market was valued at USD 48.4 billion in 2020 and is predicted to surpass USD 82.5 bn by 2030 with a CAGR of 5.7% from forecast period 2021 to 2030.

Get the sample copy of this report@ https://www.precedenceresearch.com/sample/1185

Growth Factors:

Factors such as growing prevalence of chronic disorders, increasing number of clinical trials in developing regions, growing number of biologics, increasing demand for advanced treatments such as personalized medicines, outbreak of viral diseases, increasing cases of cancer globally, growing geriatric population and growing research and development expenditure are propelling the clinical trials market expansion across the globe. Additional aspects that are anticipated to fuel this industry are increasing popularity of contract research organizations (CROs) and technological innovations. Constant collaborations and partnerships between major market players in order to launch new and innovative technologies have enhanced the demand for overall market for the clinical trials market.

Contract research organizations (CROs) are vital to the biotech, pharmaceutical, and medical devices industries as they support efforts of the client company to test, enhance, and market the modern pharmaceutical products and medical devices.

Report Scope of the Clinical Trials Market

Report Highlights Details
Market Size USD 82.5 Billion by 2030
Growth Rate CAGR of 5.7% from 2021 to 2030
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Phase, Study Design, Indication

Report Highlights:

  • Among the phase segment, phase 3 dominated the overall market in 2020. Involvement of large number of participants and high cost is the major reason for high market share of phase 3 clinical trials.
  • The interventional study accounted for the largest revenue in the study design segment with more than 46% share in 2020. Factors such as high use in drug and biologics studies and technological innovations drive the growth of interventional study.
  • Oncology accounted for the largest revenue in the indication segment. High prevalence of cancer in developing regions is the key reason for high market share of oncology.
  • The key companies included in the analysis are Parexel, IQVIA, Charles River Laboratory, Omnicare, Kendle, Chiltern, and Pharmaceutical Product Development, LLC. Among others. IQVIA accounted for a significant share of the global clinical trials market.

Regional Analysis:

The report covers data for North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. In 2020, North America dominated the global market with a market share of more than 52%. U.S. represented the highest share in the North American region primarily due to presence of latest healthcare infrastructure and early adoption of new technologies in clinical research. Furthermore, high investment by major market players also contributed to the high market share of the United States.

Europe was the second important market chiefly due to presence of skilled researchers and increasing research and development activities. High incidence of chronic disorders in the European region is also expected to boost the demand for clinical trials market in the near future. Asia Pacific is anticipated to grow at the maximum CAGR of around 6.7% in the forecast period due to high incidence of viral disorders. Latin America and the African and Middle Eastern region will display noticeable growth.

Get your Customized Research Report@ https://www.precedenceresearch.com/customization/1185

Recent report on the Clinical Trials market, with the help of a comprehensive outlook, provides readers with an assessment of the global market landscape. This study on the Clinical Trials market analyzes the scenario for the period of 2017 to 2030, wherein, 2021 is the base year and 2020 is historical data. This report enables readers to make important decisions with regard to their business, with the help of a wealth of Information enclosed in the study. The report also provides the compound annual growth rate (CAGR) of the global Clinical Trials market for the forecast period of 2021–2030. This data can help readers interpret quantitative growth aspects of the global market during the forecast period. It presents a wealth of information on key market dynamics, including drivers, market trends, and challenges, as well as the structure of the global market across the globe.

The report analyzes the historical and present-day scenario of the global Clinical Trials market to accurately gauge its growth potential. The study presents detailed information about important growth factors, restraints, and key trends that are creating the landscape for growth of the global market in order to identify opportunities for stakeholders.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the Clinical Trials market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the market.

The report delves into the competition landscape of the global Clinical Trials market. Key players operating in the market have been identified and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the Clinical Trials market that are profiled in this report.

Y-o-Y growth comparison, volume and revenue comparison, and market share comparison of various market segments are provided in the report. The Clinical Trials market is analyzed at both regional and country levels.

Clinical Trials Market top Key Players:

  • Parexel
  • IQVIA
  • Charles River Laboratory
  • Omnicare
  • Kendle
  • Chiltern
  • Pharmaceutical Product Development, LLC

Clinical Trials Market Segmentation

By Phase

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4

By Study Design

  • Observational
  • Interventional
  • Expanded Access

By Indication

  • Oncology
  • Autoimmune/Inflammation
  • Diabetes
  • Central Nervous System
  • Cardiovascular
  • Pain Management
  • Others

Research Methodology

A unique research methodology has been utilized to conduct a comprehensive research on the growth of the global Clinical Trials market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions. Secondary sources referred to by analysts during the production of the global market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of our study on the market as a primary source.

These primary and secondary sources provided exclusive information during interviews, which serves as a validation from mattress topper industry leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global Clinical Trials market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped to estimates the future prospects of the global market more reliable and accurate.

Key Questions are

  • What are the key factors influencing the Clinical Trials market in each region?
  • How much value will the global market generate by the end of the forecast period?
  • What will be the CAGR of the global market between 2021 and 2030?
  • What would be the Y-o-Y growth trend of the global market between 2021 and 2030?
  • What is the future scope and current trends in technologies of the global market?
  • What is the revenue of the global market based on segments?
  • Which key strategies are used by top players of the global market?
  • Which are the leading companies in the global market?
  • What are the essential strategies by key stakeholders in the market to expand their geographic presence?
  • What are the major advancements witnessed in the global market?

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Clinical Trials Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Clinical Trials Market

5.1. Covid-19: Clinical Trials Industry Impact
5.2. Clinical Trials Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Clinical Trials Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Clinical Trials Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Clinical Trials Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Growing prevalence of chronic disorders
6.1.1.2. Increasing number of clinical trials in developing regions
6.1.2. Market Restraints
6.1.2.1. Rigorous guidelines
6.1.3. Market Opportunities
6.1.3.1. Increasing demand for advanced treatments such as personalized medicines
6.1.3.2. Technological advancements

Chapter 7. Global Clinical Trials Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Clinical Trials Market Revenue by Market Players (2016 -2019)
7.1.1.2. Clinical Trials Market Revenue Market Share by Market Players (2016 -2019)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Phase Portfolio Expansion, Geographic Expansion, Phase Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Clinical Trials Market, By Phase

8.1. Clinical Trials Market, by Phase, 2017 – 2030
8.1.1. Phase 1
8.1.1.1. Market Revenue and Forecast (2017 – 2030)
8.1.2. Phase 2
8.1.2.1. Market Revenue and Forecast (2017 – 2030)
8.1.3. Phase 3
8.1.3.1. Market Revenue and Forecast (2017 – 2030)
8.1.4. Phase 4
8.1.4.1. Market Revenue and Forecast (2017 – 2030)

Chapter 9. Global Clinical Trials Market, By Study Design

9.1. Clinical Trials Market, by Study Design, 2017 – 2030
9.1.1. Observational
9.1.1.1. Market Revenue and Forecast (2017 – 2030)
9.1.2. Interventional
9.1.2.1. Market Revenue and Forecast (2017 – 2030)
9.1.3. Expanded Access
9.1.3.1. Market Revenue and Forecast (2017 – 2030)

Chapter 10. Global Clinical Trials Market, By Indication

10.1. Clinical Trials Market, by Indication, 2017 – 2030
10.1.1. Oncology
10.1.1.1. Market Revenue and Forecast (2017 – 2030)
10.1.2. Autoimmune/Inflammation
10.1.2.1. Market Revenue and Forecast (2017 – 2030)
10.1.3. Diabetes
10.1.3.1. Market Revenue and Forecast (2017 – 2030)
10.1.4. Central Nervous System
10.1.4.1. Market Revenue and Forecast (2017 – 2030)
10.1.5. Cardiovascular
10.1.5.1. Market Revenue and Forecast (2017 – 2030)
10.1.6. Pain Management
10.1.7. Market Revenue and Forecast (2017 – 2030)
10.1.8. Others
10.1.8.1. Market Revenue and Forecast (2017 – 2030)

Chapter 11. Global Clinical Trials Market, Regional Estimates and Trend Forecast

11.1. North America
11.1.1. Market Revenue Forecast by Phase(2017 – 2030)
11.1.2. Market Revenue Forecast by Study Design(2017 – 2030)
11.1.3. Market Revenue Forecast by Indication (2017 – 2030)
11.1.4. U.S
11.1.4.1. Market Revenue Forecast (2017 – 2030)
11.1.5. Canada
11.1.5.1. Market Revenue Forecast (2017 – 2030)
11.2. Europe
11.2.1. Market Revenue Forecast by Phase (2017 – 2030)
11.2.2. Market Revenue Forecast by Study Design (2017 – 2030)
11.2.3. Market Revenue Forecast by Indication (2017 – 2030)
11.2.4. UK
11.2.4.1. Market Revenue Forecast (2017 – 2030)
11.2.5. Germany
11.2.5.1. Market Revenue Forecast (2017 – 2030)
11.2.6. France
11.2.6.1. Market Revenue Forecast (2017 – 2030)
11.2.7. Rest of EU
11.2.7.1. Market Revenue Forecast (2017 – 2030)
11.3. Asia Pacific (APAC)
11.3.1. Market Revenue Forecast by Phase (2017 – 2030)
11.3.2. Market Revenue Forecast by Study Design (2017 – 2030)
11.3.3. Market Revenue Forecast by Indication (2017 – 2030)
11.3.4. China
11.3.4.1. Market Revenue Forecast (2017 – 2030)
11.3.5. India
11.3.5.1. Market Revenue Forecast (2017 – 2030)
11.3.6. Japan
11.3.6.1. Market Revenue Forecast (2017 – 2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue Forecast (2017 – 2030)
11.4. LATAM
11.4.1. Market Revenue Forecast by Phase (2017 – 2030)
11.4.2. Market Revenue Forecast by Study Design (2017 – 2030)
11.4.3. Market Revenue Forecast by Indication (2017 – 2030)
11.4.4. Brazil
11.4.4.1. Market Revenue Forecast (2017 – 2030)
11.4.5. Rest of LATAM
11.4.5.1. Market Revenue Forecast (2017 – 2030)
11.5. Middle East and Africa (MEA)
11.5.1. Market Revenue Forecast by Phase (2017 – 2030)
11.5.2. Market Revenue Forecast by Study Design (2017 – 2030)
11.5.3. Market Revenue Forecast by Indication (2017 – 2030)
11.5.4. GCC
11.5.4.1. Market Revenue Forecast (2017 – 2030)
11.5.5. North Africa
11.5.5.1. Market Revenue Forecast (2017 – 2030)
11.5.6. South Africa
11.5.6.1. Market Revenue Forecast (2017 – 2030)
11.5.7. Rest of MEA
11.5.7.1. Market Revenue Forecast (2017 – 2030)

Chapter 12. Company Profiles

12.1. Parexel
12.1.1. Company Overview, Business Information, Regional Presence
12.1.2. Phase Portfolio Analysis
12.1.2.1. Product Details, Specification, Indication
12.1.3. Revenue, Price, and Gross Margin (2017 – 2020)
12.1.4. Recent Developments and Strategies
12.2. IQVIA
12.2.1. Company Overview, Business Information, Regional Presence
12.2.2. Phase Portfolio Analysis
12.2.2.1. Product Details, Specification, Indication
12.2.3. Revenue, Price, and Gross Margin (2017 – 2020)
12.2.4. Recent Developments and Strategies
12.3. Charles River Laboratory
12.3.1. Company Overview, Business Information, Regional Presence
12.3.2. Phase Portfolio Analysis
12.3.2.1. Product Details, Specification, Indication
12.3.3. Revenue, Price, and Gross Margin (2017 – 2020)
12.3.4. Recent Developments and Strategies
12.4. Omnicare
12.4.1. Company Overview, Business Information, Regional Presence
12.4.2. Phase Portfolio Analysis
12.4.2.1. Product Details, Specification, Indication
12.4.3. Revenue, Price, and Gross Margin (2017 – 2020)
12.4.4. Recent Developments and Strategies
12.5. Kendle
12.5.1. Company Overview, Business Information, Regional Presence
12.5.2. Phase Portfolio Analysis
12.5.2.1. Product Details, Specification, Indication
12.5.3. Revenue, Price, and Gross Margin (2017 – 2020)
12.5.4. Recent Developments and Strategies
12.6. Chiltern
12.6.1. Company Overview, Business Information, Regional Presence
12.6.2. Phase Portfolio Analysis
12.6.2.1. Product Details, Specification, Indication
12.6.3. Revenue, Price, and Gross Margin (2017 – 2020)
12.6.4. Recent Developments and Strategies
12.7. Pharmaceutical Product Development, LLC
12.7.1. Company Overview, Business Information, Regional Presence
12.7.2. Phase Portfolio Analysis
12.7.2.1. Product Details, Specification, Indication
12.7.3. Revenue, Price, and Gross Margin (2017 – 2020)
12.7.4. Recent Developments and Strategies
12.8. Company 8
12.8.1. Company Overview, Business Information, Regional Presence
12.8.2. Phase Portfolio Analysis
12.8.2.1. Product Details, Specification, Indication
12.8.3. Revenue, Price, and Gross Margin (2017 – 2020)
12.8.4. Recent Developments and Strategies
12.9. Company 9
12.9.1. Company Overview, Business Information, Regional Presence
12.9.2. Phase Portfolio Analysis
12.9.2.1. Product Details, Specification, Indication
12.9.3. Revenue, Price, and Gross Margin (2017 – 2020)
12.9.4. Recent Developments and Strategies
12.10. Company 10
12.10.1. Company Overview, Business Information, Regional Presence
12.10.2. Phase Portfolio Analysis
12.10.2.1. Product Details, Specification, Indication
12.10.3. Revenue, Price, and Gross Margin (2017 – 2020)
12.10.4. Recent Developments and Strategies

Chapter 13. Appendix

13.1. About Us
13.2. Glossary of Terms

Buy this Research Report study@ https://www.precedenceresearch.com/checkout/1185

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 9197 992 333

About Us

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

For Latest Update Follow Us:

https://www.linkedin.com/company/precedence-research/

https://www.facebook.com/precedenceresearch/

https://twitter.com/Precedence_R

 

James Root

James Root have over 6+ years of experience working in business development, and customer retention. I’ve gained my experience through serving higher education, healthcare, automotive, aerospace, manufacturing, local government and hospitality businesses with technical solutions.

View all posts by James Root →